USE OF BLUEM IN THE NON-SURGICAL TREATMENT OF PERI-IMPLANT MUCOSITIS: A RANDOMIZED CONTROLLED CLINICAL TRIAL
Peri-implant mucositis; non-surgical treatment; chemical agent.
Peri-implant mucositis is an inflammatory condition without bone loss that occurs in the soft tissues surrounding the implant. Non-surgical treatment combines basic therapy with or without the use of chemical agents. Therefore, this objective study evaluates the efficacy of Bluem as a chemical adjuvant in the treatment of peri-implant mucositis in a non-surgical treatment protocol, considering the periodontal and peri-implant clinical parameters (visible plaque index (VPI), gingival bleeding index (GBI), probing depth (PD) and bleeding on probing (BOP). The implants in this study were allocated into two groups that received non-surgical treatment: 33 implants received basic therapy associated with the chemical agent Bluem (test) and 38 implants received basic therapy associated with the use of placebo (control). Patients were followed up at baseline, 15 days, 03, 06 and 12 months. Given the normality of the data, the 2-way ANOVA test for repeated measures, as well as Fisher's exact test to verify the association between the dependent and independent variables were used with a significance level of 5%. Regarding oral hygiene indexes (VPI and GBI), there was a reduction in VPI and GBI for the test group and a reduction in PD and BOP for both the test group (Bluem) and the control group (placebo), with no interaction between time and type of treatment. Given the results, Bluem can be used as an alternative for the non-surgical treatment of peri-implant mucositis, however, its efficacy still requires additional studies for scientific evidence.